The medical development necessitates a treatment regimen involving blood thinners, which is expected to sideline the signal-caller for at least three months. Consequently, the Eagles have placed Hurts on injured reserve, effectively ending his participation for the current campaign.
Medical Timeline and Diagnosis
The situation began on October 15 while the team was in London for their matchup against the Jacksonville Jaguars. Following an ultrasound, medical staff discovered a superficial blood clot. At that time, it was determined that the clot was low-risk, and Hurts was cleared to participate in the game, with medical professionals emphasizing the importance of mobility.
However, the condition progressed significantly in the following days. A follow-up ultrasound conducted last Wednesday revealed that the clot had moved, leading to the more severe diagnosis of deep vein thrombosis and pulmonary emboli. Hurts was subsequently ruled out of the team's recent game against the Carolina Panthers before being moved to the injured reserve list.
Understanding the Condition and Recovery
While medical experts not involved in the case note that superficial vein thrombosis can sometimes be managed with conservative treatments like compression and anti-inflammatory medication, the progression to deep vein thrombosis and
Because blood thinners significantly increase the risk of bleeding, contact sports are strictly avoided during the recovery period. While the team initially monitored the superficial clot to allow for continued play, the subsequent migration of the clot necessitated a shift in treatment strategy. The focus for the organization and the player has now shifted entirely to his recovery and long-term health, with the quarterback expected to remain off the field for the duration of his treatment plan.
